Core Laboratories Inc. (NYSE:CLB – Get Free Report) has received a consensus recommendation of “Reduce” from the four brokerages that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating and two have issued a hold rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $18.50.
Several analysts have issued reports on CLB shares. Piper Sandler cut their price target on shares of Core Laboratories from $18.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday, July 15th. Bank of America cut their price target on shares of Core Laboratories from $16.00 to $15.00 and set an “underperform” rating for the company in a research report on Monday, July 15th. Stifel Nicolaus increased their target price on shares of Core Laboratories from $18.00 to $22.00 and gave the stock a “hold” rating in a report on Friday, July 26th. Finally, StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Friday, July 26th.
Read Our Latest Stock Report on CLB
Hedge Funds Weigh In On Core Laboratories
Core Laboratories Trading Down 4.8 %
Core Laboratories stock opened at $18.33 on Friday. Core Laboratories has a fifty-two week low of $13.82 and a fifty-two week high of $26.49. The firm’s fifty day moving average price is $20.79 and its 200-day moving average price is $18.07. The stock has a market cap of $859.68 million, a P/E ratio of 20.83, a PEG ratio of 1.47 and a beta of 2.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.68 and a current ratio of 2.39.
Core Laboratories (NYSE:CLB – Get Free Report) last posted its quarterly earnings results on Wednesday, July 24th. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01. Core Laboratories had a net margin of 5.44% and a return on equity of 15.20%. The business had revenue of $130.58 million during the quarter, compared to analyst estimates of $132.85 million. During the same period in the prior year, the business posted $0.23 earnings per share. The company’s revenue was up 2.1% on a year-over-year basis. Equities research analysts forecast that Core Laboratories will post 0.71 earnings per share for the current fiscal year.
Core Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, August 26th. Stockholders of record on Monday, August 5th will be issued a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, August 5th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.22%. Core Laboratories’s dividend payout ratio is currently 4.55%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
See Also
- Five stocks we like better than Core Laboratories
- What is a Low P/E Ratio and What Does it Tell Investors?
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- Learn Technical Analysis Skills to Master the Stock Market
- Lowe’s Stock: Hold Now, Buy it When it Dips
- High Dividend REITs: Are They an Ideal Way to Diversify?
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.